Concordia Pharmaceuticals INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$61Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
952clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| William Salt | Columbus, OH | Gastroenterology (Internal Medicine) | $8,468.20 |
| Dennis Min | Middletown, OH | Gastroenterology (Internal Medicine) | $7,979.64 |
| Dushyant Viswanathan | Woodland Hills, CA | Internal Medicine | $4,345.02 |
| Peyton Berookim | Beverly Hills, CA | Internal Medicine | $4,270.25 |
| Marvin Singh | Rochester, NY | Gastroenterology (Internal Medicine) | $2,264.87 |
| Robert Theobald | Tampa, FL | Colon & Rectal Surgery | $741.14 |
| Andrew Dupont | Houston, TX | Gastroenterology (Internal Medicine) | $402.84 |
| Yuriy Israel | Forest Hills, NY | Gastroenterology (Internal Medicine) | $325.38 |
| Samuel Davidoff | Forest Hills, NY | Gastroenterology (Internal Medicine) | $297.95 |
| Annie Chemmanur | Framingham, MA | Gastroenterology (Internal Medicine) | $287.06 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.